午夜视频在线播放,久久久无码精品亚洲A片消消乐

国产一级婬片A片免费无成人黑豆,亚洲AV无码乱码精品,黄色网址免费在线观看,少妇高潮久久久久久潘金莲

<noscript id="ccccc"><optgroup id="ccccc"></optgroup></noscript>

CN

CN EN

Latest News

Latest News Media Downloads Video Center

Kexing Biopharm's clinical trial application accepted for human interferon α1b inhalation solution
2022-08-19

2022-08-19

On the evening of August 18, 2022, Kexing Biopharm...
Kexing Biopharm's clinical trial application accepted for another dosage form of human interferon α2b
2022-08-15

2022-08-15

On the evening of August 14, 2022, Kexing Biopharm Co., Ltd. (hereinafter referred to as "the Company" or "Kexing Biopharm") announced that it had recently received the Notice of Acceptance, an administrative license document issued by the National Medical Products Administration (hereinafter referred to as "NMPA"), indicating that its clinical trial application for "Human Interferon α2b Spray" was accepted.
Kexing Biopharm's clinical trial application accepted for "Pegylated Human Granulocyte Colony-stimulating Factor Injection"
2022-08-02

2022-08-02

On the evening of August 1, 2022, Kexing Biopharm Co., Ltd. (hereinafter referred to as "the Company" or "Kexing Biopharm") announced that it had just received the Notice of Acceptance, an administrative license document issued by the National Medical Products Administration (hereinafter referred to as "NMPA"), indicating that its clinical trial application for "Pegylated Human Granulocyte Colony-stimulating Factor Injection" was accepted.
Kexing Biopharm's conference for reviewing operation and management in first half of 2022and planning key tasks for the second half-year held successfully
2022-08-01

2022-08-01

In the face of the complicated political and economic environment in China and overseas as well as the tough situation in the pharmaceutical industry, Kexing Biopharm proposed the working policy themed as "intensely licensing in new products, firmly promoting R&D and innovation, and proactively creating business in new industries" at the beginning of the year, and continuously followed and implemented the policy in the first half-year.
Phase I clinical trial kick-off meeting of Kexing Biopharm's COVID-19 oral drug SHEN26 Capsule held successfully
2022-07-22

2022-07-22

On July 20, 2022, the phase I clinical trial kick-off meeting of SHEN26 Capsule, a small-molecule oral drug against COVID-19 jointly developed by Shenzhen Kexing Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Kexing Biopharm (688136.SH), and Shenzhen Antiv Pharma Co., Ltd., was successfully held in the Second Affiliated Hospital of Anhui Medical University, indicating the official start of the clinical study for the project.

1 2 3 4 5

Support Hotline

0755-26546500
Online Consultation
QR Code

Scan Code Consultation

日本寡妇高潮免费毛片 | 艹b喷水捆绑在线观看 | 亚洲国产二区V在线观看 | 91在线无码精品秘国产色多多 | 波多野结衣一区二区三区在线观看 | 成人精品一区二区三区有限 | 成人无码一二三产区入口 | 欧美一级黃色A片韩国 | 熟女大屁股白浆一二区国产精品 | 免费观看av的网站 | 色狠狠一区二区三区香蕉 | 无码国产伦一区二区三区视频 | 亚洲精品中文字幕在线观看 | 国产一级a一级a免费视频 | 久久精品国产999大香线蕉 | 男人女人爱爱视频网站 | 久久久久无码精品国产 | 污开车视频免费在线观看 | 东北女人毛多水多A片 | 看黄色一级免费的黄色视频 | 成人午夜在线视频 | 亚洲精品视频在线观看免费 | 三男玩一女免费A级 | 久久久久久久久久国产 | 国产一级片在线观看网站 | 午夜无码精品一区二区三区99午 | 国产乱人伦无无码视频 | 4444www大胆无码视频 | 搡60岁老女人老太婆免费 | 国产免费一区二区三区在线观看 | 四虎8848成人免费观看 | 波多野结衣无码在线 | wwyw913国产成人精品 | 在线观看高清无码视频 | 欧一美一性一交一精品 | 白丝小仙女 91在线竹菊丨国产熟女视 | 蜜臀久久99精品久久久无需会员 | 性爱一级毛片丰满少妇 | 精产品99永久免费网页版 | 熟女少妇人妻白浆一区二区偷拍 | 国产肥白大熟妇BBBB视频 |

<nav id="c0cc0"><code id="c0cc0"></code></nav>

<noscript id="c0cc0"></noscript>